Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.
by Kevin McLaughlin
Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
Judy Pearson was surprised by the demands of cancer survivorship. Here, she offers tips on how to look at life after cancer.
by Judy Pearson
Amid continued research showing the impact of COVID-19 on people with cancer, patients are asking when they should get a COVID-19 vaccine.
by Marci A. Landsmann
Stool-based tests could increase access to colorectal cancer screening.
by Jen Tota McGivney
Some cancer patients struggle to find transportation to their appointments. The coronavirus pandemic has further limited options for patients looking for rides.
Rich Nardiello seeks to bring a smile to children with cancer.
by Bradley Jones
Rebecca Dresser explores the history and burdens of clinical trials through the lens of a cancer survivor and medical ethicist.
Researchers study ways to improve telehealth capabilities, clinical trials and health disparities.
by Trevan Locke, PhD
Breast cancer patients’ symptoms after radiation therapy may go underrecognized, especially if these patients are Black or younger in age.
Survival statistics are important—and sometimes confusing. Cancer Today spoke with statistics experts about what these numbers really mean.
by Ashley P. Taylor
Researchers are studying the effectiveness of drugs for treating COVID-19 in cancer patients who have been infected with the coronavirus.
by Marcus A. Banks
The AACR led a contingent of 130 organizations in asking that cancer patients and survivors be granted high priority in receiving COVID-19 vaccinations.
Eliminating disparities requires consistent effort on numerous fronts, including the development and sustenance of a diverse scientific workforce.
In March of last year, screenings for breast, colon and cervical cancer decreased by roughly 90% compared with historical rates.
Learning Medicare’s ABCDs
donate to the AACR